Update on chemoradiotherapy for head and neck cancer

Current Opinion in Oncology

Volumn 14, Issue 3, 2002, Pages 323-329

  Argiris, Athanassios ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HEAD AND NECK CANCER; HUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; REVIEW; SIDE EFFECT;

CLINICAL TRIALS; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 0036256065     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200205000-00012     Document Type: Review

References (24)

1. Head and neck cancer
2. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
3. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial, EORTC Head and Neck Cancer Cooperative Group
4. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors
5. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data
6. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
7. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
8. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage orophaynx carcinoma
9. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck
10. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial
11. A phase III comparison of standard radiation therapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-fluorouracil (5FU) in patients with unresectable squamous cell head and neck cancer (SCHNC): An Intergroup study
12. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers
13. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: Results of a multicentric randomized German trial in advanced head-and-neck cancer
14. Accelerated chemoradiation to 70.6 Gy is more effective than accelerated radiation to 77.6 Gy alone: Two year's results of a German multicenter randomized trial (Aro 95-6)
15. Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup Trial R91-11
16. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
17. Superiority of five year survival with chemo-radiotherapy vs radiotherapy in patients with locally advanced nasopharyngeal cancer. Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Phase III Study: Final report
18. Altered fractionation for head and neck cancer
19. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer
20. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale Mitomycin Randomized trials
21. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
22. Very accelerated RT vesus accelerated RT+concomitant CDDP-5FU in patients with palpable N2 and N3 HNSCC: Preliminary results of the GORTEC 96-01 randomized trial
23. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma
24. A phase II randomized trial of concurrent radiation and chemotherapy for advanced squamous cell of the head and neck: Preliminary survival and toxicity outcomes